Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
500 results
  1. NLM Digital Collections - Academic Medical Centers 
    https://resource.nlm.nih.gov/101662437X835
    ... P. MARTIN, T. R. EASTERLING CONSENSUS STATEMENT Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: Recommendations of an International AIDS Society- ...
  2. NLM Digital Collections - Chronic hepatitis C virus infection : developing direct-acting antiviral drugs for treatment 
    Publication: Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
    resource.nlm.nih.gov/101719919
    ... analogue NS5B polymerase inhibitors) should be assessed before testing combinations of the drugs in HIV-1/HCV co-infected patients. f. Resistance and cross-resistance Sponsors should examine in cell ...
  3. NLM Digital Collections - Future Directions in AIDS Research (Madison, WI), 1993 July 30-31 
    https://resource.nlm.nih.gov/101647507X92
    ... order to prevent or delay the onset of resistance to individual compounds. Objectives: « Faciitate clinical testing of HIV antivirel compounds in combination which may delay or eliminate development of individual drug resistence. . ¢ ° © Share relevant information gained from preclinical and ...
  4. NLM Digital Collections - 7/1/1987-8/13/1987 
    https://resource.nlm.nih.gov/101637321X46
    ... is essential to the success of counseling and testing programs that persons who are tested for HIV are not subjected to inappropriate discrimination. REFERENCES CDC. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus ...
  5. Management of Dental Patients Who Are HIV Positive: Summary - AHRQ Evidence Report Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK11965
    ... and control for immunological and clinical HIV status, HIV viral replication rates, prior history ... much more research already exists regarding treatment ...
  6. NLM Digital Collections - Briefing Book for Hearings, 1988-1990 
    https://resource.nlm.nih.gov/101083016X43
    ... Predictive Value of Human Immunodefici- ency Virus (HIV) Testing in Reference Laboratory for Vart- ous Populations Prevalence Positive of HIV Predictive Infecuon* Valuet Populations with msk factors Homosexual male or intravenous drug user from highest preva- lence areas O5 0. ...
  7. NLM Digital Collections - American Red Cross, 1992 
    https://resource.nlm.nih.gov/101647507X142
    ... considerably more potent in blocking © growth of the HIV virus in human cells ... early testing of other non-nucleoside reverse transcriptase inhibitors, Upjohn ...
  8. NLM Digital Collections - 10/1/1987-11/30/1987 
    https://resource.nlm.nih.gov/101637321X50
    ... is essential to the success of counseling and testing programs that persons who are tested for HIV are not subjected to inappropriate discrimi- nation. References 1. CDC. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus ...
  9. NLM Digital Collections - 4/2/1990-5/30/1990 
    https://resource.nlm.nih.gov/101637321X72
    ... is essential to the success of counseling and testing programs that persons who are tested for HIV are not subjected to inappropriate discrimi- nation. References 1. CDC. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus ...
  10. NLM Digital Collections - 8/20/1988-9/23/1988 
    https://resource.nlm.nih.gov/101637321X63
    ... is essential to the success of counseling and testing programs that persons who are tested for HIV are not subjected to inappropriate discrimi- nation. References 1. COC. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last